Deletion, anergy, and a spectrum of functional impairments can affect virus-specific CD8 cells in chronic viral infections. Here we characterize a low frequency population of CD8 cells present in chronic hepatitis B virus (HBV) infection which survive in the face of a high quantity of viral antigen. Although they do not appear to exert immunological pressure in vivo, these CD8 cells are not classically “tolerant” since they proliferate, lyse, and produce antiviral cytokines in vitro. They are characterized by altered HLA/peptide tetramer reactivity, which is not explained by TCR down-regulation or reduced functional avidity and which can be reversed with repetitive stimulation. CD8 cells with altered tetramer binding appear to have a specificity restricted to envelope antigen and not to other HBV antigens, suggesting that mechanisms of CD8 cell dysfunction are differentially regulated according to the antigenic form and presentation of individual viral antigens.
Skip Nav Destination
Article navigation
6 May 2002
Article|
May 06 2002
Escaping High Viral Load Exhaustion : CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection
Stephanie Reignat,
Stephanie Reignat
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Search for other works by this author on:
George J.M. Webster,
George J.M. Webster
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
Search for other works by this author on:
David Brown,
David Brown
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
Search for other works by this author on:
Graham S. Ogg,
Graham S. Ogg
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Abigail King,
Abigail King
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Suranjith L. Seneviratne,
Suranjith L. Seneviratne
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Search for other works by this author on:
Geoff Dusheiko,
Geoff Dusheiko
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
Search for other works by this author on:
Roger Williams,
Roger Williams
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Search for other works by this author on:
Mala K. Maini,
Mala K. Maini
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Search for other works by this author on:
Antonio Bertoletti
Antonio Bertoletti
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Search for other works by this author on:
Stephanie Reignat
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
George J.M. Webster
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
David Brown
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
Graham S. Ogg
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Abigail King
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Suranjith L. Seneviratne
3Molecular Immunology Group, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, United Kingdom
Geoff Dusheiko
2Centre for Hepatology, Royal Free Campus, Royal Free and University College Medical School, London NW3 2QG, United Kingdom
Roger Williams
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Mala K. Maini
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Antonio Bertoletti
1Institute of Hepatology, University College London, London WC1 E6HX, United Kingdom
Address correspondence to Antonio Bertoletti, Institute of Hepatology, University College London 69-75, Chenies Mews, London WC1 E6HX, UK. Phone: 44-20-7679 6517; Fax: 44-20-7679 0405; E-mail: [email protected]
*
Abbreviations used in this paper: HBV, hepatitis B virus; ICCS, intracellular cytokine staining; tet/neg, tetramer negative; tet/pos, tetramer positive.
Received:
October 12 2001
Revision Received:
February 25 2002
Accepted:
March 08 2002
Online ISSN: 1540-9538
Print ISSN: 0022-1007
The Rockefeller University Press
2002
J Exp Med (2002) 195 (9): 1089–1101.
Article history
Received:
October 12 2001
Revision Received:
February 25 2002
Accepted:
March 08 2002
Citation
Stephanie Reignat, George J.M. Webster, David Brown, Graham S. Ogg, Abigail King, Suranjith L. Seneviratne, Geoff Dusheiko, Roger Williams, Mala K. Maini, Antonio Bertoletti; Escaping High Viral Load Exhaustion : CD8 Cells with Altered Tetramer Binding in Chronic Hepatitis B Virus Infection . J Exp Med 6 May 2002; 195 (9): 1089–1101. doi: https://doi.org/10.1084/jem.20011723
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement